Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimized proteins

B C Cunningham1, J A Wells

  • 1Department of Protein Engineering, Genentech Inc., San Francisco, CA 94080, USA. bcc@gene.com

Current Opinion in Structural Biology
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Designing drugs for large protein-protein interfaces is hard. Mini-proteins, created through design or selection, offer a promising strategy for developing new therapeutics targeting these interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Invasive MRI of Blood-Cerebrospinal Fluid Barrier Function.

Nature communications·2020
Same author

CNS distribution, signalling properties and central effects of G-protein coupled receptor 4.

Neuropharmacology·2018
Same author

Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease.

NeuroImage·2017
Same author

MRI of cerebral micro-vascular flow patterns: A multi-direction diffusion-weighted ASL approach.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2016
Same author

Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues.

Cell death and differentiation·2016
Same author

Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease.

NeuroImage·2015
Same journal

Tomogram exploration through template matching and deep learning.

Current opinion in structural biology·2026
Same journal

A comparative review of cryo-electron ptychography: Biological applications and future perspectives.

Current opinion in structural biology·2026
Same journal

Metabolic disruptions through a three-dimensional genomic lens.

Current opinion in structural biology·2026
Same journal

Collective variable design for biomolecular conformational dynamics.

Current opinion in structural biology·2026
Same journal

Polymer scaling in protein crowding: From dilute coils to semidilute meshes.

Current opinion in structural biology·2026
Same journal

Tuning the physicochemical properties of rationally designed protein-based biomolecular condensates.

Current opinion in structural biology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Drug Discovery
  • Molecular Biology

Background:

  • Targeting protein-protein interactions (PPIs) is crucial for drug development.
  • Designing small molecules for large PPIs presents significant challenges.
  • Minimizing protein structures offers a novel therapeutic avenue.

Purpose of the Study:

  • To explore the potential of 'mini-proteins' as an intermediate step in drug design.
  • To investigate methods for creating smaller, functional protein analogs.
  • To address the challenge of targeting large protein-protein interfaces.

Main Methods:

  • Rational design of minimized protein structures.
  • Selection from vast combinatorial libraries for functional polypeptides.
  • Characterization of designed mini-proteins for bioactivity.

Related Experiment Videos

Main Results:

  • Successful minimization of proteins into smaller polypeptides.
  • Demonstration of mini-proteins as viable intermediates for drug development.
  • Advancement in strategies for targeting challenging protein-protein interfaces.

Conclusions:

  • Mini-proteins represent a promising strategy for developing drugs against protein-protein interfaces.
  • Both rational design and library selection are effective methods for creating mini-proteins.
  • This approach offers a new direction for overcoming limitations in current drug discovery for PPIs.